Abstract

Ischemic injury caused by stroke is one of the leading causes of severe morbidity and mortality. Neuronal loss, proliferation of reactive astrocytes and the formation of a glial scar represent the three critical problems preventing the functional recovery. Direct reprogramming of astrocytes into neurons in vivo using NeuroD1‐containing AAV virus represents a new promising gene therapy capable of replenishing the neuronal population and reducing gliosis. We have used NeuroD1‐containing AAV virus to convert astrocytes into neurons in the mouse primary visual cortex (V1) following focal ischemic injury. We have demonstrated that this in vivo reprogramming can restore visual evoked potentials (VEPs) and individual neuronal responses impaired after ischemic injury in V1. We have used Channelrhodopsin Assisted Circuit Mapping (CRACM) to demonstrate that this functional restoration is accompanied by the integration of the newly reprogrammed neurons into the visual microcircuit and reestablishment of the specific interlaminar long‐range connections. Our work suggests that in vivo NeuroD1‐based viral therapy can convert reactive astrocytes into neurons and restore visual function lost after local ischemiaSupport or Funding InformationPurdue Research Foundation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call